Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2019 / Cilt: 52 - Sayı: 1

Breast cancer and family history for breast cancer in patients with differentiated thyroid carcinoma

Pages
79–82
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our study is the first report to show history of breast cancer and family history of breast cancer as 0.7 % and 13.4 % in this particular group of Turkish patients with differentiated thyroid cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The risk for breast cancer in patients with thyroid cancer has been investigated in previous studies, and has been found to be increased.
📊
Key Findings & Data:Methods: We conducted a retrospective study involving 455 patients who were diagnosed as having differentiated thyroid carcinoma between January 2009 and March 2016.
💡
Conclusion & Impact:Our study is the first report to show history of breast cancer and family history of breast cancer as 0.7 % and 13.4 % in this particular group of Turkish patients with differentiated thyroid cancer.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Breast cancer · thyroid cancer

Özet

Purpose: The risk for breast cancer in patients with thyroid cancer has been investigated in previous studies, and has been found to be increased. In this study, we present a retrospective analysis of patients with differentiated thyroid carcinoma in respect to breast cancer and family history of breast cancer. Methods: We conducted a retrospective study involving 455 patients who were diagnosed as having differentiated thyroid carcinoma between January 2009 and March 2016. Results: The majority of the patents were female (403, 88.6 %). The mean age at diagnosis was 45.5 ± 12.8 years (range, 10-81 years). We detected that 0.7 % patients with thyroid cancer had breast cancer and 13.4 % patients had a family history of breast cancer within 3 generations of the proband. There were no significant differences between family history of breast cancer and sex, age at diagnosis, pathologic types, and radioiodine therapy. Conclusion: In the literature, there are many clinical, epidemiologic, and experimental studies that show an association between thyroid cancer and breast cancer. Our study is the first report to show history of breast cancer and family history of breast cancer as 0.7 % and 13.4 % in this particular group of Turkish patients with differentiated thyroid cancer.

🔖

Cite This Article

KARAKÖSE, M., ÖZBEK, M., AKIN, Ş., ÇAKAL, E., ÖZÇELİK, Ö., ÜNSAL, İ., UÇAN, B., SENCAR, E., APAYDIN, M., SAKIZ, D. (2022). Breast cancer and family history for breast cancer in patients with differentiated thyroid carcinoma. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 52 - Sayı: 1, 79–82. https://ajindex.com/articles/441289

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. The oncologist. 2007; 12:20-37.2. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115:3801-7.3. Garner CN, Ganetzky R, Brainard J, et al. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery. 2007; 142:806-13; discussion 13 e1-3.4. Joseph KR, Edirimanne S, Eslick GD. The association between breast cancer and thyroid cancer: a meta-analysis. Breast cancer research and treatment. 2015; 152:173-81.5. Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley CS. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer. 1999; 85:696-705.6. Kuo JH, Chabot JA, Lee JA. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database. Surgery. 2016; 159:23-9.7. An JH, Hwangbo Y, Ahn HY, et al. A Possible Association Between Thyroid Cancer and Breast Cancer. Thyroid: official journal of the American Thyroid Association. 2015; 25:1330-8.8. Subramanian S, Goldstein DP, Parlea L, et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid: official journal of the American Thyroid Association. 2007; 17:1277-88.9. Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS, Ridgway EC. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. American journal of epidemiology. 1988; 127:969-80.10. Ron E, Curtis R, Hoffman DA, Flannery JT. Multiple primary breast and thyroid cancer. British journal of cancer. 1984; 49:87-92.11. Kumar A, Klinge CM, Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. International journal of oncology. 2010; 36:1067-80.12. Vivacqua A, Bonofiglio D, Albanito L, et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Molecular pharmacology. 2006; 70:1414-23.13. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. The Journal of clinical endocrinology and metabolism. 2008; 93:504-15.14. Consort